February 14, 2025

Benzene Formation in Benzoyl Peroxide: Formulation’s Role

Researchers found that benzene formation in benzoyl peroxide products is influenced by formulation factors, with hot processing increasing levels and antioxidants reducing them.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

January 24, 2025

Acne Vulgaris Linked to Gastrointestinal Comorbidities Conditions

“Study shows patients with acne vulgaris face significantly higher risks of GI comorbidities, including peptic ulcers and IBS."

Conexiant

April 26, 2024

Preclinical Work May Lay Groundwork for Future Targeted Acne Therapies

Researchers may have uncovered factors contributing to the functional divergence of human commensal Cutibacterium acnes bacteria.

Conexiant

September 23, 2024

Physicians Urged to Scrutinize Employers Beyond Salary

Beyond salary and work-life balance, physicians seeking new roles should evaluate potential employers' governance, reward systems, and culture, according to a viewpoint published in JAMA Internal Medicine.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

April 30, 2024

High Levels of Benzene Discovered in Acne Treatments

High levels of the carcinogen benzene have been found in many common acne treatments containing benzoyl peroxide.

Conexiant

October 11, 2024

Skin Pigmentation: Rethinking Drug Efficacy

With skin pigmentation influencing drug binding and potentially altering therapeutic outcomes, understanding melanin's role in pharmacokinetics is key to advancing equitable treatments.

Conexiant

November 26, 2024

Do Cancer Drugs Trigger Skin Issues?

A recent analysis reveals that nearly 50% of significant dermatologic adverse events linked to anticancer therapies are associated with targeted therapies, with rash, dry skin, and alopecia being the most commonly reported adverse events.

Conexiant